Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 6/2008

01.06.2008 | Article

Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis

verfasst von: E. E. Hill, W. E. Peetermans, S. Vanderschueren, P. Claus, M.-C. Herregods, P. Herijgers

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

The incidence of methicillin-resistant Staphylococcus aureus (MRSA) infective endocarditis (IE) is increasing. This study compared clinical characteristics and mortality in patients with methicillin-sensitive S. aureus (MSSA) IE versus MRSA IE, based on a prospectively collected series of 72 consecutive patients with definite S. aureus IE according to the modified Duke criteria between June 2000 and December 2006. Sixteen of 72 IE patients (22%) were caused by MRSA. Nosocomial origin, surgical site infection, surgery in the previous 6 months, the presence of a catheter and persistent bacteremia were significantly associated with MRSA. MSSA patients had significantly more unknown origin of bacteremia and experienced a significantly higher rate of major embolism than MRSA patients. MSSA patients underwent more frequently combined surgical and antimicrobial therapy, and MRSA patients were treated more frequently with antimicrobial therapy due to a contraindication to surgery. The 6-month mortality was higher in patients with MRSA than MSSA. In the MSSA group treated with antimicrobial therapy without an indication to surgery, all patients survived, and in the combined surgical and antimicrobial group 29% died. The mortality in MRSA patients was lowest if combined surgical and antimicrobial therapy was performed. Both in MSSA and MRSA patients with antimicrobial therapy due to a contraindication to surgery, the mortality was extremely high. These data suggest that in S. aureus IE patients with a nosocomial origin, the presence of a catheter or recent surgery, initial therapy should include antimicrobial agents active against MRSA. Antimicrobial therapy alone with close monitoring of the therapeutic effect and signs of complicated course is an acceptable approach in selected patients with MSSA IE. Denial of surgery because of local or general factors in patients that meet criteria for surgical intervention in acute IE is prognostically ominous.
Literatur
1.
Zurück zum Zitat Mylonakis E, Calderwood SB (2001) Medical progress: Infective endocarditis in adults. N Engl J Med 345:1318–1330PubMedCrossRef Mylonakis E, Calderwood SB (2001) Medical progress: Infective endocarditis in adults. N Engl J Med 345:1318–1330PubMedCrossRef
2.
Zurück zum Zitat Mouly S, Ruimy R, Launay O, Arnoult F, Brochet E, Trouillet JL, Leport C, Wolff M (2002) The changing clinical aspects of infective endocarditis: Descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect 45:246–256PubMedCrossRef Mouly S, Ruimy R, Launay O, Arnoult F, Brochet E, Trouillet JL, Leport C, Wolff M (2002) The changing clinical aspects of infective endocarditis: Descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect 45:246–256PubMedCrossRef
3.
Zurück zum Zitat Loupa C, Mavroidi N, Boutsikakis I, Paniara O, Deligarou O, Manoli H, Saroglou G (2004) Infective endocarditis in Greece: a changing profile. Epidemiological, microbiological and therapeutic data. Clin Microbiol Infect 10:556–561PubMedCrossRef Loupa C, Mavroidi N, Boutsikakis I, Paniara O, Deligarou O, Manoli H, Saroglou G (2004) Infective endocarditis in Greece: a changing profile. Epidemiological, microbiological and therapeutic data. Clin Microbiol Infect 10:556–561PubMedCrossRef
4.
Zurück zum Zitat Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012–3021PubMedCrossRef Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012–3021PubMedCrossRef
5.
Zurück zum Zitat Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE (2007) Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 28(2):196–203PubMedCrossRef Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE (2007) Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 28(2):196–203PubMedCrossRef
6.
Zurück zum Zitat Cabell CH, Abrutyn E, Fowler VG Jr, Hoen B, Miro JM, Corey GR, Olaison L, Pappas P, Anstrom KJ, Stafford JA, Eykyn S, Habib G, Mestres CA, Wang A (2005) Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J 150:1092–1098PubMedCrossRef Cabell CH, Abrutyn E, Fowler VG Jr, Hoen B, Miro JM, Corey GR, Olaison L, Pappas P, Anstrom KJ, Stafford JA, Eykyn S, Habib G, Mestres CA, Wang A (2005) Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J 150:1092–1098PubMedCrossRef
7.
Zurück zum Zitat Yoon HJ, Choi JY, Kim CO, Kim JM, Song YG (2005) A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis. Yonsei Med J 46:496–502PubMedCrossRef Yoon HJ, Choi JY, Kim CO, Kim JM, Song YG (2005) A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis. Yonsei Med J 46:496–502PubMedCrossRef
8.
Zurück zum Zitat Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM, O’Donnell A, Wagener MM, Yu VL (2003) A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82:322–332CrossRef Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM, O’Donnell A, Wagener MM, Yu VL (2003) A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82:322–332CrossRef
9.
Zurück zum Zitat Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638PubMedCrossRef Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638PubMedCrossRef
10.
Zurück zum Zitat Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT (1995) Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 274:1706–1713PubMedCrossRef Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT (1995) Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 274:1706–1713PubMedCrossRef
11.
Zurück zum Zitat Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111:3167–3184CrossRef Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111:3167–3184CrossRef
12.
Zurück zum Zitat Moon MR, Stinson EB, Miller DC (1997) Surgical treatment of endocarditis. Prog Cardiovasc Dis 40:239–264PubMedCrossRef Moon MR, Stinson EB, Miller DC (1997) Surgical treatment of endocarditis. Prog Cardiovasc Dis 40:239–264PubMedCrossRef
13.
Zurück zum Zitat Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, Soler-Soler J, Thiene G, von Graevenitz A, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernandez Burgos E, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Lekakis J, Vahanian A, Delahaye F, Parkhomenko A, Filipatos G, Aldershvile J, Vardas P (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis - Executive summary. Eur Heart J 25:267–276PubMedCrossRef Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, Soler-Soler J, Thiene G, von Graevenitz A, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernandez Burgos E, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Lekakis J, Vahanian A, Delahaye F, Parkhomenko A, Filipatos G, Aldershvile J, Vardas P (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis - Executive summary. Eur Heart J 25:267–276PubMedCrossRef
14.
Zurück zum Zitat Mermel LA, Farr BM, Sherertz RJ, Raad II, O’Grady N, Harris JS, Craven DE (2001) Guidelines for the management of intravascular catheter related infections. Clin Infect Dis 32:1249–1272PubMedCrossRef Mermel LA, Farr BM, Sherertz RJ, Raad II, O’Grady N, Harris JS, Craven DE (2001) Guidelines for the management of intravascular catheter related infections. Clin Infect Dis 32:1249–1272PubMedCrossRef
15.
Zurück zum Zitat Chen SC, Dwyer DE, Sorrell TC (1992) A comparison of hospital and community-acquired infective endocarditis. Am J Cardiol 70:1449–1452PubMedCrossRef Chen SC, Dwyer DE, Sorrell TC (1992) A comparison of hospital and community-acquired infective endocarditis. Am J Cardiol 70:1449–1452PubMedCrossRef
16.
Zurück zum Zitat Terpenning MS, Buggy BP, Kauffman CA (1988) Hospital-acquired infective endocarditis. Arch Intern Med 148:1601–1603PubMedCrossRef Terpenning MS, Buggy BP, Kauffman CA (1988) Hospital-acquired infective endocarditis. Arch Intern Med 148:1601–1603PubMedCrossRef
17.
Zurück zum Zitat Hsu RB (2005) Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 26:654–657PubMedCrossRef Hsu RB (2005) Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 26:654–657PubMedCrossRef
18.
Zurück zum Zitat Levine DP, Fromm BS, Reddy BR (1991) Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 115:674–680PubMed Levine DP, Fromm BS, Reddy BR (1991) Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 115:674–680PubMed
19.
Zurück zum Zitat Valtonen V, Kuikka A, Syrjanen J (1993) Thrombo-embolic complications in bacteraemic infections. Eur Heart J 14(Suppl K):20–23PubMed Valtonen V, Kuikka A, Syrjanen J (1993) Thrombo-embolic complications in bacteraemic infections. Eur Heart J 14(Suppl K):20–23PubMed
20.
Zurück zum Zitat Syrjanen J (1993) Infection as a risk factor for cerebral infarction. Eur Heart J 14(Suppl K):17–19PubMed Syrjanen J (1993) Infection as a risk factor for cerebral infarction. Eur Heart J 14(Suppl K):17–19PubMed
21.
Zurück zum Zitat Vaudaux PE, Monzillo V, Francois P, Lew DP, Foster TJ, Berger-Bachi B (1998) Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins. Antimicrob Agents Chemother 42:564–570PubMed Vaudaux PE, Monzillo V, Francois P, Lew DP, Foster TJ, Berger-Bachi B (1998) Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins. Antimicrob Agents Chemother 42:564–570PubMed
Metadaten
Titel
Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis
verfasst von
E. E. Hill
W. E. Peetermans
S. Vanderschueren
P. Claus
M.-C. Herregods
P. Herijgers
Publikationsdatum
01.06.2008
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 6/2008
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0458-2

Weitere Artikel der Ausgabe 6/2008

European Journal of Clinical Microbiology & Infectious Diseases 6/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.